JXX-28876-54503
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 319 / GA
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Dose 1 — Pfizer-BioNTech
-
2021-01-04
Registered in v-safe
-
2021-01-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-17
-
2021-01-23
Dose 2 — Moderna
- 2021-01-23
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-04-26
- 2021-07-24
-
2021-11-02
Dose 3 — Moderna
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
-
2021-12-07
Survey response — day 35, dose 3MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased MigrainesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-07
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-08
- 2021-12-14
- 2022-02-01
-
2022-05-03
Survey response — 6 months, dose 3MedDRA: Office visit, Pregnancy — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): ObMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-05-04
-
2022-11-02
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-02
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-11-03
- 2022-11-03
- 2022-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Pfizer-BioNTech | |
| 2 | 2021-01-23 | Moderna | |
| 3 | 2021-11-02 | Moderna | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 10 — day 35, dose 3
Symptoms: Increased Migraines
Release 11 — 6 months, dose 3
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release